In the high-stakes world of venture capital, where the pursuit of the "next big thing" often leads investors to the fringes of experimental technology, Joshua Kushner’s Thrive Capital has made a move that is as contrarian as it is calculated. The firm, widely recognized for its early and aggressive backing of private titans like OpenAI, [
Monday, July 27
